Holen Sie sich die Stockscreener-App
29.05
1.36%
0.39
Schlusskurs vom Vortag:
$28.66
Offen:
$28.67
24-Stunden-Volumen:
254.68K
Relative Volume:
1.18
Marktkapitalisierung:
$1.21B
Einnahmen:
$376.97M
Nettoeinkommen (Verlust:
$-8.36M
KGV:
-41.50
EPS:
-0.7
Netto-Cashflow:
$10.17M
1W Leistung:
+6.92%
1M Leistung:
+9.75%
6M Leistung:
+22.16%
1J Leistung:
+65.91%
1-Tages-Spanne:
$28.67
$29.20
1-Wochen-Bereich:
$27.11
$29.20
52-Wochen-Spanne:
$16.48
$30.00
Artivion Inc Stock (AORT) Company Profile
Firmenname
Artivion Inc
Sektor
Branche
Telefon
(770) 419-3355
Adresse
1655 ROBERTS BOULEVARD N W, KENNESAW
Vergleichen Sie AORT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
29.05 | 1.21B | 376.97M | -8.36M | 10.17M | -0.70 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-27 | Bestätigt | Lake Street | Buy |
| 2022-08-08 | Eingeleitet | Lake Street | Buy |
| 2022-03-03 | Eingeleitet | Stifel | Buy |
Artivion Inc Aktie (AORT) Neueste Nachrichten
Artivion Insiders Sell US$2.9m Of Stock, Possibly Signalling Caution - Simply Wall St
Artivion, Inc. (NYSE:AORT) Holdings Increased by Quest Partners LLC - MarketBeat
Artivion (FRA:CYL) Owner Earnings per Share (TTM) : -0.18 (As of Sep. 2024) - GuruFocus.com
Royce & Associates LP Has $23.19 Million Stake in Artivion, Inc. (NYSE:AORT) - MarketBeat
Artivion, Inc. (NYSE:AORT) Q3 2024 Earnings Call Transcript - Insider Monkey
Artivion Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Artivion Inc (AORT) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Artivion Inc (AORT) Quarterly 10-Q Report - Quartzy
Artivion Inc Com (AORT) Quarterly 10-Q Report - Quartzy
Artivion Inc (AORT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances - Yahoo Finance
Where Artivion Stands With Analysts - Benzinga
Wellington Management Group LLP's Strategic Acquisition in Artiv - GuruFocus.com
Artivion (NYSE:AORT) Given New $32.00 Price Target at Oppenheimer - MarketBeat
Artivion stock price target raised on strong Q3 performance By Investing.com - Investing.com UK
Artivion (AORT) Tops Q3 Earnings and Revenue Estimates - MSN
Artivion: Q3 Earnings Snapshot - Houston Chronicle
Artivion stock price target raised on strong Q3 performance - Investing.com
Artivion reports Q3 non-GAAP EPS 12c, consensus (6c) - TipRanks
Artivion’s Q3 2024: Revenue Growth and Strategic Progress - TipRanks
Artivion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Artivion Inc (AORT) Q3 2024 Earnings: Revenue Hits $95.8M, EPS L - GuruFocus.com
Artivion Reports Third Quarter 2024 Financial Results - PR Newswire
When Should You Buy Artivion, Inc. (NYSE:AORT)? - Simply Wall St
Earnings To Watch: Artivion Inc (AORT) Reports Q3 2024 Result - GuruFocus.com
Artivion to Participate in Upcoming Investor Conferences - StockTitan
Artivion (AORT) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Artivion started at market outperform by JMP, stent graft devices cited - MSN
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results - StockTitan
Artivion (NYSE:AORT) Shares Gap UpHere's Why - MarketBeat
The Latest Analyst Ratings For Artivion - Benzinga
JMP Securities Initiates Coverage on Artivion (NYSE:AORT) - MarketBeat
JMP bullish on Artivion stock, cites EBITDA growth and advanced stent graft division - Investing.com
Artivion (NYSE:AORT) delivers shareholders splendid 111% return over 1 year, surging 5.7% in the last week alone - Simply Wall St
Artivion reports positive trial results for aortic treatments - Investing.com
Artivion reports positive trial results for aortic treatments By Investing.com - Investing.com UK
Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - PR Newswire
Artivion Inc (AORT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Artivion executive sells over $325k in company stock - Investing.com
Artivion executive sells over $325k in company stock By Investing.com - Investing.com South Africa
Amy Horton Sells 12,430 Shares of Artivion, Inc. (NYSE:AORT) Stock - MarketBeat
Dimensional Fund Advisors LP Sells 25,701 Shares of Artivion, Inc. (NYSE:AORT) - MarketBeat
Perceptive Advisors LLC Has $71.66 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Artivion (NYSE:AORT) Trading 5.9% Higher - MarketBeat
Artivion Inc (AORT) Shares Up 5.22% on Sep 27 - GuruFocus.com
Artivion (NYSE:AORT) Receives Buy Rating from Needham & Company LLC - MarketBeat
Those who invested in Artivion (NYSE:AORT) a year ago are up 61% - Yahoo Finance
Can Artivion's Strong Vital Signs Lead To Further Stock Gains? - RTTNews
Check Out Artivion Inc (AORT)’s Trade Data Rather Than the Analysts’ Views - SETE News
First Eagle Investment Management LLC Acquires 27,906 Shares of Artivion, Inc. (NYSE:AORT) - MarketBeat
Atkore Inc. to Attend the 2024 RBC Capital Markets Global Industrials Conference - sharewise
(AORT) Trading Signals - Stock Traders Daily
Finanzdaten der Artivion Inc-Aktie (AORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):